ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

XERMELO
Cytoprotective and supportive care agents
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

XERMELO

Generic Name and Formulations:
Telotristat ethyl 250mg; tabs.

Company:
Lexicon Pharmaceuticals

Therapeutic Use:

Indications for XERMELO:

In combination with somatostatin analog (SSA) therapy, to treat carcinoid syndrome diarrhea in adults inadequately controlled by SSA therapy.

Adult:

Take with food. 250mg 3 times daily.

Children:

Not established.

Warnings/Precautions:

Monitor for constipation and/or severe, persistent, or worsening abdominal pain; discontinue if develops. ESRD requiring dialysis: not studied. Pregnancy. Nursing mothers: monitor infant for constipation.

Interactions:

May antagonize CYP3A4 substrates (eg, midazolam); monitor and consider increasing dose of concomitant substrates if necessary. Antagonized by short-acting octreotide; if concomitant use is necessary, give dose ≥30mins after Xermelo.

Pharmacological Class:

Tryptophan hydroxylase inhibitor.

Adverse Reactions:

Nausea, headache, increased GGT, depression, flatulence, decreased appetite, peripheral edema, pyrexia.

Generic Availability:

NO

How Supplied:

Monthly carton—4 x 7 daily dose packs

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs